← Back to Search

Remote PCIT for Disruptive Behavior (AI I-PCIT Trial)

N/A
Waitlist Available
Led By Magdalena Romanowicz, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, approximately 2 years
Awards & highlights

AI I-PCIT Trial Summary

This trial aims to see if remote PCIT therapy with wearables can help children with disruptive behaviors. #mentalhealth

Eligible Conditions
  • Disruptive Behavior

AI I-PCIT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, approximately 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, approximately 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluating parental acceptance of remote PCIT augmented with a Garmin device
How wearing a Garmin watch will help the remote PCIT clinical outcomes
Number of participants able to wear the Garmin watch throughout remote PCIT
Secondary outcome measures
Evaluating clinical improvement from remote PCIT in regards to parental reports of behavior accuracy of indirect behavioral measures from wearable devices to parental ratings
Evaluating clinical improvement from remote PCIT in regards to sleep
Evaluating measured sleep data throughout remote PCIT

AI I-PCIT Trial Design

1Treatment groups
Experimental Treatment
Group I: Wearable Device InterventionExperimental Treatment1 Intervention
An open label, non randomized trial that requires all participants to wear a Garmin watch throughout the course of the trial (~12 weeks).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Remote PCIT augmented with wearable devices
2023
N/A
~10

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,208 Previous Clinical Trials
3,767,045 Total Patients Enrolled
1 Trials studying Disruptive Behavior
100 Patients Enrolled for Disruptive Behavior
Magdalena Romanowicz, MDPrincipal InvestigatorMayo Clinic

Media Library

Remote PCIT augmented with wearable devices Clinical Trial Eligibility Overview. Trial Name: NCT05725525 — N/A
Disruptive Behavior Research Study Groups: Wearable Device Intervention
Disruptive Behavior Clinical Trial 2023: Remote PCIT augmented with wearable devices Highlights & Side Effects. Trial Name: NCT05725525 — N/A
Remote PCIT augmented with wearable devices 2023 Treatment Timeline for Medical Study. Trial Name: NCT05725525 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies still available for participation in this experiment?

"Clinicaltrials.gov reveals that this clinical trial is actively seeking participants, with the original posting on March 2nd of 2023 and updated data as recent as 7th of the same month."

Answered by AI

What is the total capacity of participants in this experiment?

"Affirmative. According to information available on clinicaltrials.gov, this trial is seeking volunteers for enrollment and began recruiting on March 2nd of 2023 with the latest update posted a few days later. They are specifically looking for 100 individuals from one medical center."

Answered by AI

Are there specific requirements for individuals wishing to take part in this experiment?

"In this clinical trial, up to 100 people depicting disruptive behavior aged between 3 and 99 will be recruited. Key eligibility criteria include the capacity for informed consent, fluency in English language by both patient and guardian, a score of ≥120 on Eyberg Child Behavior Inventory scale (Eyberg & Pincus 1999), access to technology/internet for remote therapy visits along with agreement to wear Garmin watch."

Answered by AI

Are geriatric individuals eligible to participate in this scientific inquiry?

"This medical study is open to those aged 3 and over, up to the age of 99."

Answered by AI
~2 spots leftby Apr 2025